MX2023014435A - Inhibidores de la tirosina quinasa de bruton y métodos de su uso. - Google Patents
Inhibidores de la tirosina quinasa de bruton y métodos de su uso.Info
- Publication number
- MX2023014435A MX2023014435A MX2023014435A MX2023014435A MX2023014435A MX 2023014435 A MX2023014435 A MX 2023014435A MX 2023014435 A MX2023014435 A MX 2023014435A MX 2023014435 A MX2023014435 A MX 2023014435A MX 2023014435 A MX2023014435 A MX 2023014435A
- Authority
- MX
- Mexico
- Prior art keywords
- bruton
- methods
- tyrosine kinase
- kinase inhibitors
- malignancies
- Prior art date
Links
- 102000001714 Agammaglobulinaemia Tyrosine Kinase Human genes 0.000 title 1
- 108010029445 Agammaglobulinaemia Tyrosine Kinase Proteins 0.000 title 1
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 title 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000036210 malignancy Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163196843P | 2021-06-04 | 2021-06-04 | |
| PCT/IB2022/055154 WO2022254371A1 (en) | 2021-06-04 | 2022-06-02 | Inhibitors of bruton's tyrosine kinase and methods of their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023014435A true MX2023014435A (es) | 2024-03-08 |
Family
ID=82214195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023014435A MX2023014435A (es) | 2021-06-04 | 2022-06-02 | Inhibidores de la tirosina quinasa de bruton y métodos de su uso. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230013755A1 (enExample) |
| EP (1) | EP4346834A1 (enExample) |
| JP (1) | JP2024520630A (enExample) |
| KR (1) | KR20240019214A (enExample) |
| CN (1) | CN117412753A (enExample) |
| AU (1) | AU2022284369A1 (enExample) |
| BR (1) | BR112023025459A2 (enExample) |
| CA (1) | CA3220015A1 (enExample) |
| CL (2) | CL2023003564A1 (enExample) |
| IL (1) | IL308951A (enExample) |
| JO (1) | JOP20230310A1 (enExample) |
| MX (1) | MX2023014435A (enExample) |
| TW (1) | TW202317127A (enExample) |
| WO (1) | WO2022254371A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11964976B1 (en) | 2023-09-12 | 2024-04-23 | King Faisal University | Substituted pyrido[3′,4′:4,5]pyrrolo[3,2-c][1,6]naphthyridines as CK2 inhibitors |
| WO2025228889A1 (en) | 2024-04-30 | 2025-11-06 | Boehringer Ingelheim International Gmbh | Monoarylic heterocyclic compounds as sting antagonists and the use thereof as medicament |
| WO2025228900A1 (en) | 2024-04-30 | 2025-11-06 | Boehringer Ingelheim International Gmbh | Arylamide substituted indazoles and the use thereof as medicament |
| US20250333414A1 (en) | 2024-04-30 | 2025-10-30 | Boehringer Ingelheim International Gmbh | Hetaryl substituted indazoles and benzimidazoles as sting antagonists and the use thereof as medicament |
| WO2025228899A1 (en) | 2024-04-30 | 2025-11-06 | Boehringer Ingelheim International Gmbh | Further heterocyclic compounds as sting antagonists and the use thereof as medicament |
| US20250333398A1 (en) | 2024-04-30 | 2025-10-30 | Boehringer Ingelheim International Gmbh | Monoaryl and hetaryl substituted indazoles and benzimidazoles as sting antagonists and the use thereof as medicament |
| WO2025228902A1 (en) | 2024-04-30 | 2025-11-06 | Boehringer Ingelheim International Gmbh | Heterocyclic acids as sting antagonists and the use thereof as medicament |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2887697A1 (en) | 2012-10-11 | 2014-04-17 | Pharmacyclics, Inc. | Companion diagnostics for tec family kinase inhibitor therapy |
| PL3179991T3 (pl) * | 2014-08-11 | 2022-02-14 | Acerta Pharma B.V. | Kombinacje terapeutyczne inhibitora btk i inhibitora bcl-2 |
| JO3794B1 (ar) | 2015-12-10 | 2021-01-31 | Janssen Pharmaceutica Nv | المركبات متعددة الحلقات كمثبطات لتيروزين كيناز بروتون |
| WO2018103060A1 (en) * | 2016-12-09 | 2018-06-14 | Janssen Pharmaceutica Nv | Inhibitors of bruton's tyrosine kinase and methods of their use |
-
2022
- 2022-06-02 AU AU2022284369A patent/AU2022284369A1/en active Pending
- 2022-06-02 EP EP22733732.6A patent/EP4346834A1/en active Pending
- 2022-06-02 WO PCT/IB2022/055154 patent/WO2022254371A1/en not_active Ceased
- 2022-06-02 US US17/830,714 patent/US20230013755A1/en active Pending
- 2022-06-02 KR KR1020247000043A patent/KR20240019214A/ko active Pending
- 2022-06-02 TW TW111120615A patent/TW202317127A/zh unknown
- 2022-06-02 CA CA3220015A patent/CA3220015A1/en active Pending
- 2022-06-02 BR BR112023025459A patent/BR112023025459A2/pt unknown
- 2022-06-02 CN CN202280039736.2A patent/CN117412753A/zh active Pending
- 2022-06-02 JP JP2023574315A patent/JP2024520630A/ja active Pending
- 2022-06-02 IL IL308951A patent/IL308951A/en unknown
- 2022-06-02 MX MX2023014435A patent/MX2023014435A/es unknown
-
2023
- 2023-11-29 CL CL2023003564A patent/CL2023003564A1/es unknown
- 2023-11-29 JO JOJO/P/2023/0310A patent/JOP20230310A1/ar unknown
-
2024
- 2024-09-26 CL CL2024002895A patent/CL2024002895A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3220015A1 (en) | 2022-12-08 |
| EP4346834A1 (en) | 2024-04-10 |
| IL308951A (en) | 2024-01-01 |
| KR20240019214A (ko) | 2024-02-14 |
| JOP20230310A1 (ar) | 2023-11-29 |
| US20230013755A1 (en) | 2023-01-19 |
| JP2024520630A (ja) | 2024-05-24 |
| WO2022254371A1 (en) | 2022-12-08 |
| CL2024002895A1 (es) | 2025-02-14 |
| TW202317127A (zh) | 2023-05-01 |
| CN117412753A (zh) | 2024-01-16 |
| AU2022284369A1 (en) | 2024-01-25 |
| BR112023025459A2 (pt) | 2024-02-27 |
| CL2023003564A1 (es) | 2024-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023014435A (es) | Inhibidores de la tirosina quinasa de bruton y métodos de su uso. | |
| PH12021551402A1 (en) | Substituted pyrazolopyrimidines and substituted purines and their use as ubiquitin-specific-processing protease 1 (usp1) inhibitors | |
| EA200300906A1 (ru) | Новые спиротрициклические производные и их применение в качестве ингибиторов фосфодиэстеразы-7 | |
| ATE499097T1 (de) | Monozyklische heterozyklen als kinase-hemmer | |
| MX2022001151A (es) | Inhibidores deuterados de la via mk2 y metodos de uso de los mismos. | |
| EA201070480A1 (ru) | Ингибиторы с-fms киназы | |
| EA202092154A1 (ru) | Комбинированная терапия | |
| EA200700220A1 (ru) | Имидазотриазины в качестве ингибиторов протеинкиназы | |
| DK1272188T3 (da) | Anvendelse af EGFR-tyrosinkinaseinhibitorer til behandling af brystcancer | |
| EA200400482A1 (ru) | Кератиноциты, пригодные для применения в качестве биологически активной субстанции при лечении ран | |
| MX386700B (es) | Inhibidores de la tirosina quinasa de bruton y metodos de su uso. | |
| PT1362047E (pt) | Compostos de pirrolina substituidos com indazolilo como inibidores de cinase | |
| EA200300306A1 (ru) | Спиропиримидин-2,4,6-трионовые ингибиторы металлопротеиназы | |
| MX2025015186A (es) | Inhibidores de pi3k y uso de estos | |
| JO3794B1 (ar) | المركبات متعددة الحلقات كمثبطات لتيروزين كيناز بروتون | |
| MX2023007265A (es) | Inhibidores de cdk y su uso como productos farmacéuticos. | |
| DE10334663A1 (de) | Harnstoffderivate | |
| DK1401413T3 (da) | Anvendelse af tyrosinkinaseinhibitorer til behandling af allergiske sygdomme | |
| MX2025002705A (es) | Isoquinolonas como inhibidores de pi3k | |
| YU21404A (sh) | Supstituisana jedinjenja benzimidazola i njihova primena u lečenju raka | |
| DK1242410T3 (da) | Nye forbindelser | |
| MX2023015147A (es) | Inhibidores de la tirosina quinasa de bruton y métodos de su uso. | |
| JOP20250005A1 (ar) | مثبطات التيروسين كيناز 2 واستخداماتها | |
| MX2022014356A (es) | Ciertas composiciones quimicas y metodos de uso de las mismas. | |
| DE60318342D1 (de) | Verwendung eines Granatapfelbaumextrakts zur Erhaltung der Haarfarbe |